MYNERVA Medical develops wearable technologies to treat diabetic neuropathy, aiming to reduce patient pain and improve mobility. Their product, Leia, is a non-invasive solution that offers personalized treatments and remote monitoring capabilities. The company focuses on providing secure and efficient digital health solutions for individuals managing this condition.
Funding
Funding not disclosed
Founders
Product
Problem
Diabetic neuropathy affects over half a billion individuals globally, leading to chronic pain and an increased risk of falls. Current treatment modalities often lack personalization and effective remote monitoring capabilities, hindering proactive management and patient well-being.
Solution
MyNerva Medical offers Leia, an AI-powered wearable neuroprosthetic designed to address the debilitating effects of diabetic neuropathy. This device delivers personalized, non-invasive electrical stimulation to target pain and improve proprioception, thereby reducing fall risk. Integrated sensors capture biomechanical data and user feedback, which are transmitted to a secure cloud platform. Proprietary algorithms analyze this data to dynamically adjust stimulation parameters and provide actionable insights for both patients and clinicians. This digital health solution facilitates remote patient monitoring and enables timely interventions to enhance mobility and quality of life.
Target Audience
The primary target audience includes individuals diagnosed with diabetic neuropathy, as well as endocrinologists, neurologists, podiatrists, and physical therapists managing this patient population.
Features
- Wearable neuroprosthetic device delivering targeted electrical stimulation for pain management and fall prevention.
- AI-driven adaptive stimulation algorithms that personalize treatment based on real-time biomechanical feedback.
- Integrated inertial measurement units (IMUs) for gait analysis and fall detection.
- Secure cloud-based platform for data aggregation, analysis, and remote patient monitoring.
- Patient mobile application for treatment adherence tracking and direct feedback submission.
- Clinician dashboard providing longitudinal data visualization and treatment efficacy reports.
- Over-the-air (OTA) software updates for continuous improvement of device functionality and AI models.